Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person16
Lazard, Inc.
Company
Latch, Inc.
Company
LA-Z-BOY INC
Company
Kindcard, Inc.
Company
Woodward, Inc.
Company
Lyft, Inc.
Company
Lazarus Edward P
Company
DILLARD'S, INC.
Company
LANDS' END, INC.
Company
LANTRONIX INC
Company
La Beaute Inc.
Company
Proto Labs Inc
Company
Blend Labs, Inc.
Company
Laredo Oil, Inc.
Company
Mastercard Inc
Company
MOBIX LABS, INC
Company
Primary record14
Lazard, Inc. filed 8-K
Item 8.01. Other Events. On November 6, 2026, Lazard, Inc., a Delaware corporation (the “Company”) filed with the Securities and Exchange Commission a prospectus supplement pursuant to Rule 424(b) under the Securities Ac
Lazard, Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. At the closing of the Acquisition, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with the Sellers’ Representatives n
Health In Tech, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 20, 2026, the Board of Directors (the “Board”) of H
Lazard, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 22, 2026, Lazard, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended September 30, 2026. A copy of the
Cantor Equity Partners VII, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Directors. Effective October 14, 2026, the b
FIRST TRUST PORTFOLIOS LP filed SCHEDULE 13G/A
0001445546-26-007617.txt : 20261014 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001445546-21-002430 0001184765 XXXXXXXX LIVE 17 Common 09/30/2026 0001278211 Lazard Global Total Return and Income Fund, Inc. 521
Lazard, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 12, 2026, Michael Gathy, Chief Accounting Officer an
Childrens Place, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 2, 2026, The Children s Place, Inc. (the Company ) ap
Turning Point Brands, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 21, 2026, Turning Point Brands, Inc. (the Company
Theravance Biopharma, Inc. filed 8-K
Item 8.01. Other Events. As previously disclosed, on June 28, 2026, Theravance Biopharma, Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (“ Theravance Biopharma ” or th
BlackRock, Inc. filed SCHEDULE 13G/A
0002012383-26-003260.txt : 20260904 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0002012383 XXXXXXXX LIVE 3 Common Stock 08/31/2026 0001311370 LAZARD INC 52110M109 30 ROCKEFELLER PLAZA NEW YORK NY 10112 Rule 13d
Lazard, Inc. filed 4
SEC form 4 filed by Lazard, Inc. (CIK 1311370) on 2026-08-26.
DOMINION ENERGY, INC filed 8-K
Item 8.01 Other Events. As previously disclosed, on May 15, 2026, Dominion Energy, Inc. (Dominion Energy) entered into an Agreement and Plan of Merger (the Merger Agreement) with NextEra Energy, Inc. (NextEra Energy), WG
Lazard, Inc. filed 4
SEC form 4 filed by Lazard, Inc. (CIK 1311370) on 2026-08-19.